Company intelligence / Profile preview

Jiangsu Gaitianli Medicine

Lianyungang, Jiangsu, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Jiangsu Gaitianli Medicine is a prominent Chinese pharmaceutical manufacturer and a subsidiary of Haisco Pharmaceutical Group. Based in Lianyungang, the company is widely recognized for its Gaitianli brand, which is a household name for calcium supplements in China. Its operations encompass the production of Traditional Chinese Medicines (TCM), chemical generics, and over-the-counter health products. The company maintains large-scale, GMP-compliant manufacturing bases to support its extensive distribution network across mainland China. Its therapeutic focus primarily includes bone health, pediatrics, and digestive health.

Therapeutic areas: GastroenterologyEndocrinologyInfectious Diseases
Modalities: Small moleculeTraditional Chinese Medicine
Industry: Biotech

Beyond the preview

Go deeper on Jiangsu Gaitianli Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Gaitianli Medicine.

Explore the full profile